Environment

Resilient and sustainable operations

We operate responsibly at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services. 

Watch Our Purpose in action: Resilient and sustainable operations to see how Cencora puts corporate responsibility into practice — advancing responsible, resilient operations that support reliable healthcare delivery.

Available in English only.

We bring innovation and efficiency to the supply chain

We operate at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services. To strengthen business continuity, we prioritize resilience by implementing advanced forecasting systems, equipping facilities with backup power sources, and conducting regular emergency preparedness training to mitigate the impact of severe weather on our operations.

Guided by our commitment to operating sustainably, we invest in innovative solutions for our buildings, product packaging, and transportation, collaborating with partners to amplify our impact. We align our corporate responsibility reporting with leading global frameworks.

Progress on our Science-Based Targets

Cencora’s climate strategy is guided by validated near-term Science-Based Targets (SBTs), with the following goals:
54.6%
Ridurre le emissioni assolute di mercato Scope 1 e 2 del 54,6% entro l'anno fiscale 2032, rispetto ai valori ristabiliti per l'anno fiscale 2019. Il ricalcolo delle emissioni dell'anno base nel 2025 doveva riflettere una maggiore accuratezza dei dati e l'integrazione tra le operazioni globali, migliorando l'integrità e la comparabilità dei nostri obiettivi nel tempo.
82%
Coinvolgere l'82% dei nostri fornitori spendendo per fissare i propri obiettivi basati sulla scienza entro il 2027, riconoscendo che la stragrande maggioranza delle nostre emissioni proviene dalla nostra catena di approvvigionamento globale.

Product integrity and patient safety

Cencora’s global infrastructure and technology support product integrity, prioritize patient safety, and drive a secure pharmaceutical supply chain. In fiscal 2025, we advanced product traceability, optimized storage conditions, and enhanced reusable packaging with temperature monitoring to safeguard shipments. Through proactive partnerships and innovative solutions, we look every day for both micro and macro opportunities to improve our operations, support healthcare providers, and protect patients worldwide.
Dopo oltre 12 anni di preparazione, Cencora è orgogliosa di essere in prima linea nell'implementazione della legge sulla sicurezza della catena di approvvigionamento dei farmaci (DSCSA) nelle sue operazioni negli Stati Uniti.
Questa legge federale migliora la tracciabilità dei farmaci da prescrizione lungo tutta la catena di fornitura, proteggendo i pazienti da prodotti contraffatti e illegittimi.
I nostri team hanno lavorato intenzionalmente per prepararsi a questo traguardo installando nuove apparecchiature, facendo progredire i sistemi, formando il settore e collaborando con partner commerciali, inclusi produttori, distributori e fornitori.

Supplier Engagement and Resiliency

At Cencora, we are united in our responsibility to create healthier futures. Our Supplier Engagement & Resiliency Program (SE&R) is an essential part of this mission, reflecting our commitment to fostering belonging and innovation in the global communities we serve. This program, embedded within our Strategic Global Sourcing Team (SGS), partners with small and disadvantaged businesses, aiming to drive economic growth, create opportunities, and deliver impactful change. 

Aligned with our Corporate Responsibility principles, Cencora’s SE&R Program is designed to support sustainable economic impact. By increasing revenues for small and disadvantaged businesses, creating jobs in underserved communities, and driving innovation, we contribute to building a more sustainable global economy.

Salute e sicurezza dei membri del team

La salute e la sicurezza dei membri del nostro team sono una pietra miliare del nostro scopo in azione. Nell'ultimo anno, abbiamo fatto passi da gigante nel migliorare i protocolli di sicurezza, migliorare la cultura del posto di lavoro e promuovere un ambiente in cui ogni membro del team si senta supportato e protetto.

Preparazione alle emergenze e risposta alle catastrofi

Fornire farmaci salvavita è una responsabilità che richiede affidabilità, anche nelle circostanze più difficili. I nostri team globali hanno lavorato con incrollabile dedizione per garantire che i pazienti ricevano terapie critiche, indipendentemente dalle interruzioni causate da disastri naturali, condizioni meteorologiche estreme o altre emergenze.

Cybersecurity, protezione dei dati e privacy

Cencora si impegna a garantire una solida sicurezza informatica, monitorando attivamente le violazioni e lavorando per rispettare il rispetto di normative come il Regolamento generale sulla protezione dei dati (GDPR), il Regolamento sanitario Assicurazione Legge sulla portabilità e la responsabilità (HIPAA) e California Consumer Privacy Act (CCPA).

Helping combat the opioid addiction

Cencora’s wholesale pharmaceutical distribution business plays a key, but specific, role of providing safe access to thousands of important medications to enable healthcare providers to serve patients with a wide array of clinical needs across the healthcare spectrum. A small part of this includes the distribution of opioids and other controlled substances from manufacturers to neighborhood pharmacies and pharmacy chains, as well as to hospitals, nursing homes, hospices, and other clinical settings. As opioid addiction continues to impact patients and families, we are taking a proactive, collaborative approach to help combat opioid misuse and abuse while also seeking to ensure access for patients with legitimate medical needs.

We have taken substantial steps to help prevent the diversion of controlled substances. Cencora has a sophisticated diversion control program through which the Company provides daily reports to the United States Drug Enforcement Administration about the quantity, type, and receiving pharmacy of every order of controlled substances that we distribute. We also work closely with other healthcare stakeholders, government entities, civic organizations, law enforcement agencies, individuals our nonprofit partners to support prescription drug safety and mental health resources in local communities. We continuously evaluate, enhance, strengthen and expand the proven measures that we have implemented to maintain the integrity of every order we ship.

Distributors such as Cencora do not manufacture or create supply or demand for opioids. The distribution of opioid medicines represents less than one percent of our annual revenue, and we do not offer our sales team members incentives based on opioid sales.

More details on our efforts to ensure safe and secure distribution, maintain operational integrity, and support legislation can be found in our periodic reports filed with the U.S. Securities and Exchange Commission at www.sec.gov and on the investor relations section of our website at investor.cencora.com/overview/default.aspx

Explore our other corporate responsibility pillars

Gente

Membri del team orientati allo scopo

Mettiamo le persone al primo posto collaborando apertamente all'interno della nostra organizzazione per promuovere un ambiente di lavoro impegnato e sostenere elevati standard etici e di conformità.

Affari e comunità

Comunità sane

Il nostro obiettivo è ampliare l’accesso all’assistenza sanitaria e accelerare i risultati sanitari nelle comunità e per i nostri clienti in tutto il mondo.

View the report

At Cencora, we are united in our responsibility to create healthier futures.
 
Available in English only.

Content index

View additional metrics easily accessible in our content index.